Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

BiondVax Pharmaceuticals Q2 EPS $(0.10) Down From $(0.03) YoY

BiondVax Pharmaceuticals (NASDAQ:BVXV) reported quarterly losses of $(0.10) per share. This is a 233.33 percent decrease over losses of $(0.03) per share from the same period last year.

byBenzinga Newsdesk

August 26, 2021

1 minute read

BiondVax Pharmaceuticals (NASDAQ:BVXV) reported quarterly losses of $(0.10) per share. This is a 233.33 percent decrease over losses of $(0.03) per share from the same period last year.

Morgan Stanley Maintains Equal-Weight on Summit Materials, Lowers Price Target to $35

By Benzinga Newsdesk

Today, 9:50 PM

Morgan Stanley maintains Summit Materials (NYSE:SUM) with a Equal-Weight and lowers the price target from $36 to $35.

SUM

Cannabis SPAC Achari Ventures Goes Public, Pricing Its IPO At $100M

By Nina Zdinjak

Today, 9:50 PM

The newest cannabis special purpose acquisition company (SPAC) Achari Ventures Holdings Corp. (NASDAQ: AVHIU) went public Friday. The company priced its initial public offering of 10 million units at $10.00 per unit.

AVHIU